The White House is dropping Heidi Overton's nomination to lead the Food and Drug Administration because of a lack of congressional support, Axios has learned.
Why it matters: The decision means the Trump administration will have to find a new candidate to lead the FDA as HHS Secretary Robert F. Kennedy Jr. looks to advance his Make America Healthy Again agenda.
"FDA nominee Heidi Overton lacks the support on the Hill to move forward with her confirmation," a senior administration official told Axios late Tuesday.
Zoom in: Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated by President Trump in August.
She had drawn criticism from segments of the MAHA movement that saw her siding with health and agriculture interests and helping undermine Kennedy agenda.
Antiabortion forces also questioned her commitment to tightening rules for prescribing the abortion pill mifepristone.
The backstory: Her nomination faced opposition from Democrats and skepticism from some…